POSTER SESSION SUBSAHARAN AFRICA FRANCOPHONE SYMPOSIUM 2023.
Authors: Andreas Ateke Njoh1,2*, Eugene Justine Kongnyuy2, Tchokfe Shalom Ndoula1, Ibrahima Madaina1, Mohamed 2 Kaba3, Laurent Cleenewerck de Kiev2
Introduction
Cervical cancer is a common cause of cancer-related mortality that significantly impacts resource-constrained countries. This condition favored by human papillomavirus (HPV) is preventable by vaccination, routine cervical cancer screening, and appropriate treatment. Vaccination is highly effective before the initiation of sexual activity. Despite HPV vaccine merit, improving coverage remained challenging in Cameroon. This paper highlights the country’s vaccine introduction strategies and progress following a single-dose gender-neutral protocol.
Methods
This August to November 2023 cross-sectional nationwide study reviewed Cameroon HPV vaccination from 2020 to June 2023. Data was collected from vaccinating staff from the country’s ten regions using an online form. The district health information software granted access to vaccination records from 2020 to 2023. Ministry of Health Reports presented national guidelines. SPSS enabled the presentation of the results in proportions. Tested values were considered statistically significant at P<0.05.
Results
Data was collected from 1225 vaccinating staff from Cameroon’s ten regions. HPV vaccine was introduced to nine to thirteen-year-old girls during COVID-19 in October 2020. National coverage remained low. Following the NITAG recommendations, vaccination included adolescent females and males from January 2023. Adhering to this recommendation, community engagement and periodic intensification of routine immunization (PIRI) led to a triple-fold increase in girls’ vaccination coverage (P=0.03). The delivery strategies include health facilities, community, and schools.
Conclusion
HPV vaccination in Cameroon has faced significant challenges. However, gender-neutral single-dose protocol, community engagement, and PIRI helped the country achieve a jump in its coverage in less than six months.
Keywords
HPV vaccination, gender-neutrality, single-dose, PIRI, Cameroon
1 Expanded Program on Immunization, Ministry of Public Health, Yaounde, Cameroon
2 School of Global Health and Bioethics, Euclid University, Bangui, Central African Republic
3 World Health Organization, Cameroon Country Office, Yaoundé, Cameroon
Correspondence*
Njoh Andreas Ateke
Tel: (+237) 675817489
Email: [email protected], [email protected]
Central Coordination EPI, Ministry of Public Health
PO Box 2 084 Yaoundé, Cameroon